Quantcast

Posts related to ‘DNA’

Bejiqcavb2e9ycazw6i8pcauk6iqhca6p_2

The Recession Damages R&D Spending (AAPL)(PFE)(MSFT)(GOOG)(DNA)

Posted: January 14, 2009 at 4:22 am

Thomas Alva Edison accumulated 1,093 US patents over his lifetime. Most R&D operations are not that efficient. Corporations hate research. It is expensive. The scientists know more about a company's ...
Read Full Story »

Top Pre-Market Analyst Upgrades (ABC, BRCM, COH, DNA, IILG, LXK, NUAN, STLD, TLAB)

Posted: October 22, 2008 at 7:02 am

These are some of the top pre-market upgrades from Wall Street analysts this Wednesday morning:AmerisourceBergen (ABC) Started as Buy at Jefferies.Broadcom (BRCM) Raised to Outperform at Baird.Coach (COH) Raised to ...
Read Full Story »
Newspaper

Media Digest 10/15/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Posted: October 15, 2008 at 2:56 am

According to Reuters, economic attention has now turned to the recession.Reuters reports that a new survey shows that half of all workers are worried about their jobsReuters reports that unions ...
Read Full Story »
Genentech_logo_2

Genentech Mixes Top-Line & Bottom-Line Numbers (DNA)

Posted: October 14, 2008 at 3:10 pm

Genentech, Inc. (NYSE: DNA) today posted earnings of $0.81 per share and $3.408 billion in revenue. That's below First Call estimates of $0.88 on $3.36 billion in revenue.  For what ...
Read Full Story »
Genentech_logo

Looking Beyond Genentech Earnings (DNA)

Posted: October 14, 2008 at 11:16 am

After today's close, we are expecting the earnings report of of biotech giant Genentech, Inc. (NYSE: DNA).  First Call estimates are for $0.88 EPS on $3.36 billion in revenue.  Today ...
Read Full Story »
Maps

Earnings On Deck: Only Nine Companies Will Matter

Posted: October 14, 2008 at 5:16 am

Analysts assume third quarter earnings for the companies in the S&P 500 will be bad. But, looking at the number which is the average of all firms in the index ...
Read Full Story »
Osi_pharma_logo_2

OSI Phase III Falls Short (OSIP, DNA)

Posted: October 6, 2008 at 7:47 am

OSI Pharmaceuticals Inc. (NASDAQ: OSIP) is getting hit hard in early trading this morning.  The biotech has released data showing that a Phase III trial of Genentech's (NYSE: DNA) Avastin ...
Read Full Story »

Top Pre-Market Analyst Upgrades (AMGN, CPLP, DRIV, DSX, DNA, GNK, MAKO)

Posted: October 2, 2008 at 7:16 am

These are some of the top upgrades we are seeing from Wall Street analysts this morning:Amgen (AMGN) Raised to Outperform at William Blair.Capital Product Partners (CPLP) Started as Outperform at ...
Read Full Story »

Early-Bird Analyst Downgrades (CMVT, CTRP, GET, DNA, HAR, JNJ, PTRY, WDFC)

Posted: August 15, 2008 at 6:13 am

These are some of the early analyst calls we are seeing early this Friday morning:Comverse Technology (CMVT) Cut to Neutral at JPMorgan.Ctrip.com (CTRP) Cut estimates and maintained Buy but target ...
Read Full Story »
Newspaper

Media Digest 8/24/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Posted: August 14, 2008 at 2:53 am

According to Reuters, Greenspan says the housing market should bottom in 2009.Reuters writes that US auto makers are scrambling to make more fuel-efficient cars.Reuters reports that the SEC is close ...
Read Full Story »
Genentech_logo

Genentech & Roche Merger Coming Under More Fire (DNA)

Posted: July 23, 2008 at 2:17 pm

Genentech Inc. (NYSE: DNA) is running into some issues over the merger with Roche at $89.00 per share.  Wall Street DOES expect this merger to close with Genentech becoming a ...
Read Full Story »
Steve_jobs

Apple (AAPL): Steve Jobs Is Fine

Posted: July 22, 2008 at 6:16 pm

Concern about the health of Apple (AAPL) CEO and founder Steve Jobs has been mounting since his appearance to launch the iPhone 3G model. He was terribly thin. Earlier this ...
Read Full Story »

Many Monday Pre-Market Downgrades (CEG, FIS, FISV, DNA, KBW, NKE, PSO, SHW, SWIR, SWK, WERN, WIT)

Posted: July 21, 2008 at 7:52 am

These are among the top analyst Downgrades or negative analyst calls affecting shares this Monday morning in pre-market trading:Constellation Energy (NYSE: CEG) Downgraded to Underperform at Jefferies.Fidelity National (NYSE: FIS) ...
Read Full Story »
Gal_genentech

Roche Tries To Torpedo Genentech (DNA) Shareholders

Posted: July 21, 2008 at 4:33 am

Swiss drug company Roche is trying to steal the part of biotech company Genentech (DNA) that it does not already own. Roche has offered to buy the 45% of DNA ...
Read Full Story »
Cnn_newsroom

Media Digest 7/21/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

Posted: July 21, 2008 at 2:52 am

According to Reuters, Roche has offered to buy-out Genentech (DNA) for $42.7 billion.Retuers reports that one of Yahoo!'s (YHOO) activist investors has called for a compromise which would put some ...
Read Full Story »